Nutrition and cancer HNH-37806
Week0
Study designs
Observational study
- Cross-sectional study
- Cohort study
- Case control study
Experimental study
- Randomized controlled trial
Cross-sectional study:
- Gather data on exposure and disease
Cohort study:
- Defined population
- Choice or circumstance
- Exposed vs not exposed
- Prospective: forward in time = longitudinal
- Direction of inquiry
Case-control study:
- Start with disease
- Retrospective-back in time
- Direction of inquiry
Experimental study / trial: clinical trial / randomized control trial
- Random allocation
- Investigator decides who gets the exposure
- Forward in time
- Direction of inquiry
Week1
Hallmarks of cancer
Clip 1
4 hallmarks directly related to growth and survival
- Sustaining proliferative signaling (growth)
- Evading growth suppressors (growth)
- Resisting cell death (survival)
- Enabling replicative immortality (survival)
Sustaining proliferative signaling = chronic proliferation: growth factors
- Increasing synthesis of growth factors by tumor cells
- Increasing synthesis of growth factors by neighboring cells
- Increasing receptors at cell surface
- Structural alterations receptors increase response
- Activation downstream pathway
Mutation in receptor: always active -> sending chronic signals to nucleus that proliferation
should be stimulated
1
,Evading growth suppressors: escape stop signal proliferation suppressors = tumor
suppressor gene
RB protein: prevents cancer cells from entering S-fase -> cancer cells mutation in RB -> RB
always inactive.
Clip 2:
Resisting cell death:
Cell death: apoptosis & autophagy ( = programmed), necrosis (acute damage; cell explodes)
Cancer cell deaths: apoptosis and autophagy decrease and necrosis increases.
P53 = damage sensor -> screens for damage in cell (G1) -> apoptosis in case of damage
Cancer cells p53 is inactivated -> no programmed cell death
Normal cell Cancer cell
Limited replication Immortalization
Shortening of telomeres Extending telomeres
Senescence/ apoptosis Alive (immortalized)
Telomerase absent / low Telomerase high
Clip 3:
Cancer cells: disseminate (spread)
Inducing angiogenesis & activating invasion and metastasis
Inducing angiogenesis
- Nutrient and oxygen supply
- Target for therapy
- Example: oncogenic stimuli -> increase VEGF -> neovascularization -> allow
metastasis
Activating invasion and metastasis = spread of cancer cells
- Via blood / lymph
Invasion-metastasis cascade
Primary tumor formation -> local invasion -> intravasation -> survival in circulation -> arrest
at distant organ site -> extravasation -> micro metastasis formation -> metastatic
colonization -> clinically detectable macroscopic metastasis
Malignant tumor = starts invading surrounding tissues or structures
EMT- epithelial-to-mesenchymal transition
(physiological process) -> phenotype of cell changes
Epithelial cells become mesenchymal cells
(carcinomas: cancers that arise from epithelial cells)
- Reverse process is MET
2
, Clip 4
Enabling and emerging characteristics
- Enabling: two additional characteristics that facilitate the other hallmarks
- Emerging: these potential hallmarks are emerging and not yet fully validated
Enabling characteristics:
Genome instability and mutation:
- Tumor suppressor genes: normal genes whose absence can lead to cancer
- Oncogens: are mutated genes whose presence can stimulate the development of
cancer
P53 = tumor suppressor gene
EGFR= oncogene
RB= tumor suppressor gene
Driver vs passenger concept
Passengers:
- Passenger mutation has no effect on neoplastic process
- Number of passenger mutation correlates with age
- Predominantly in self-renewing tissues (fast proliferating)
Drivers:
- Driver gene mutation = mutation conferring a selective growth advantage for the cell
- Impacts ratio cell birth: cell death
Tumor-promoting inflammation
- Infiltration of immune cells
- Supplying bioactive molecules to microenvironment
- Tumor inhibition as well as tumor promotion
Emerging characteristics:
Deregulating cellular energetics:
- Metabolic reprogramming for energy requirements
Avoiding immune destruction
- Escape immune surveillance
- T lymphocytes and NK cells
- Mechanisms are emerging
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller v7777777. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $7.50. You're not tied to anything after your purchase.